Announcement of GUDID Release 2.2 Deployment and Document Updates

By AHRMM

GUDID Release 2.2 was successfully deployed. The enhancements will allow for additional functionality as noted below.

  • Labelers will be able to “unlock” their device records after the DI record grace period to make error corrections. This will eliminate the need to contact the FDA UDI Help Desk to make corrections after the grace period.

Note that the Unlock functionality is intended to be used to correct data submission errors after the grace period. DO NOT USE Unlock functionality for edits that require assignment of a NEW Device Identifier. Please assign a new Device Identifier and submit a new record if you are changing data elements that are “New DI Triggers” (i.e., not correcting submission errors)

  • Addition of new data elements to the GUDID download file made available on AccessGUDID and OpenFDA to include –
  • Public Version Number
  • Public Version Date
  • Public Version Status (new/update/delete)
  • Public Device Record Key
  • Labeler DUNS Number
  • Premarket Submission Number & Supplement Number – note that this will be released after the testing/review period as indicated here.

GUDID documents (listed below) have been updated as of March 30, 2018.

We have also updated the GUDID System Enhancements and Fixes page to reflect all releases to-date.

If you have questions, concerns or feedback, please contact the FDA UDI Help Desk.

 

Related Resources

Supply Chain Strategies & Solutions Article
This article is from the November/December 2016 issue of the AHRMM member-only magazine, Supply Chain Strategies & Solutions.
Supply Chain Strategies & Solutions Article
This article is from the November/December 2016 issue of the AHRMM member-only magazine, Supply Chain Strategies & Solutions.&nbs
Supply Chain Strategies & Solutions Article
By: Suzanne Alexander-Vaughn
Supply Chain Strategies & Solutions Article
By: Karen Conway
Supply Chain Strategies & Solutions Article
Medical device manufacturers have been working hard to comply with the new Unique Device Identification (UDI) regulations from the FDA that are aim
Issue Brief
This Awareness Brief provides a quick reference to the